Amgen, CytomX Join in Immuno-Oncology Collaboration NASDAQ By John Harbison|2017-10-04T11:28:13-08:00October 4, 2017|Tech Coast Angels Portfolio Companies in the Press|Comments Off on Amgen, CytomX Join in Immuno-Oncology Collaboration Share This Story, Choose Your Platform! FacebookTwitterRedditLinkedInWhatsAppTumblrPinterestVkXingEmail About the Author: John Harbison Related Posts